Contact
Please use this form to send email to PR contact of this press release:
Zealand Pharma discloses amylin as the biological target under their 2014 agreement with Boehringer Ingelheim
TO:
Please use this form to send email to PR contact of this press release:
Zealand Pharma discloses amylin as the biological target under their 2014 agreement with Boehringer Ingelheim
TO: